Janiczek Wealth Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Janiczek Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	SELL	$58.92 - $84.67 $2,062 - $2,963	-35 Reduced 45.45%	42 $3,000
Q2 2022 Aug 03, 2022	SELL	$79.4 - $116.36 $7,463 - $10,937	-94 Reduced 54.97%	77 $6,000
Q1 2022 May 05, 2022	SELL	$86.42 - $109.81 $5,962 - $7,576	-69 Reduced 28.75%	171 $18,000
Q4 2021 Feb 02, 2022	BUY	$98.56 - $119.91 $788 - $959	8 Added 3.45%	240 $26,000
Q3 2021 Oct 19, 2021	BUY	$91.91 - $110.37 $2,389 - $2,869	26 Added 12.62%	232 $25,000
Q2 2021 Jul 28, 2021	BUY	$86.24 - $95.92 $4,829 - $5,371	56 Added 37.33%	206 $19,000
Q1 2021 Apr 28, 2021	BUY	$71.83 - $95.48 $6,177 - $8,211	86 Added 134.38%	150 $14,000
Q4 2020 Jan 26, 2021	BUY	$67.0 - $84.39 $3,886 - $4,894	58 Added 966.67%	64 $5,000
Q3 2020 Oct 19, 2020	BUY	$55.23 - $79.93 $331 - $479	6 New	6 $0

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Janiczek Wealth Management, LLC with notifications on news.